Revvity Inc. (NYSE:RVTY) Given Average Recommendation of "Hold" by Analysts

Key Points

• Analysts maintain a cautious outlook: Fifteen analysts give Revvity an average “Hold” rating, with 12 holds and three buys. The average 12-month price target is $108.36, below the reported share price of $117.66.
• Revvity exceeded quarterly expectations, reporting $1.41 in adjusted earnings per share versus the $1.21 consensus estimate and revenue of $729.69 million versus $702.96 million expected. However, quarterly revenue declined 1.3% year over year.
• Institutional investors own 86.65% of Revvity, while the company declared a quarterly dividend of $0.07, or $0.28 annualized, representing a 0.2% yield.

Shares of Revvity Inc. (NYSE:RVTY - Get Free Report) have received an average recommendation of "Hold" from the fifteen analysts that are currently covering the stock, Marketbeat reports. Twelve research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $108.3636.

A number of equities analysts have commented on RVTY shares. TD Cowen restated a "buy" rating on shares of Revvity in a research report on Wednesday, July 15th. Robert W. Baird set a $117.00 price objective on shares of Revvity in a report on Wednesday, May 6th. Wall Street Zen upgraded shares of Revvity from a "hold" rating to a "buy" rating in a research note on Saturday, August 8th. Sanford C. Bernstein assumed coverage on Revvity in a report on Friday, June 26th. They issued a "market perform" rating and a $115.00 target price on the stock. Finally, Weiss Ratings raised Revvity from a "sell (d+)" rating to a "hold (c-)" rating in a report on Thursday, July 30th.

Institutional Trading of Revvity

Several large investors have recently made changes to their positions in the business. EdgePoint Investment Group Inc. raised its holdings in shares of Revvity by 3.1% in the first quarter. EdgePoint Investment Group Inc. now owns 8,800,863 shares of the company's stock valued at $771,044,000 after buying an additional 265,204 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in Revvity by 5.3% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 8,606,637 shares of the company's stock worth $832,693,000 after buying an additional 434,570 shares in the last quarter. Janus Henderson Group PLC grew its holdings in Revvity by 2.3% during the 1st quarter. Janus Henderson Group PLC now owns 8,348,127 shares of the company's stock worth $731,386,000 after acquiring an additional 186,956 shares during the last quarter. BlackRock Inc. bought a new stake in Revvity during the 2nd quarter worth about $852,070,000. Finally, Dimensional Fund Advisors LP increased its position in Revvity by 11.7% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,917,953 shares of the company's stock valued at $255,623,000 after acquiring an additional 305,837 shares in the last quarter. Institutional investors own 86.65% of the company's stock.

Revvity Stock Up 1.7%

Shares of NYSE RVTY opened at $117.66 on Thursday. Revvity has a 52-week low of $81.22 and a 52-week high of $118.30. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.50 and a current ratio of 1.80. The business has a fifty day moving average of $108.95 and a two-hundred day moving average of $99.96. The stock has a market cap of $13.13 billion, a PE ratio of 56.03, a PEG ratio of 2.11 and a beta of 1.07.

Revvity (NYSE:RVTY - Get Free Report) last posted its earnings results on Tuesday, August 4th. The company reported $1.41 earnings per share for the quarter, topping the consensus estimate of $1.21 by $0.20. The business had revenue of $729.69 million for the quarter, compared to analyst estimates of $702.96 million. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The firm's quarterly revenue was down 1.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.18 EPS. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. As a group, equities research analysts expect that Revvity will post 5.36 earnings per share for the current fiscal year.

Revvity Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be given a $0.07 dividend. The ex-dividend date is Friday, October 23rd. This represents a $0.28 annualized dividend and a yield of 0.2%. Revvity's payout ratio is presently 13.33%.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source